Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#713 most reported symptom for this vaccine
Pulmonary congestion has been reported 23 times in association with Influenza, Seasonal (Flulaval Quadrivalent) vaccination in VAERS. This represents 0.0% of all 52,111 reports for this vaccine.
Among these reports, 1 mentioned death (4.35%) and 7 involved hospitalization (30.4%).
Pulmonary congestion is the #713 most frequently reported symptom for Influenza, Seasonal (Flulaval Quadrivalent) out of 2354 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 23 reports of Pulmonary congestion after Influenza, Seasonal (Flulaval Quadrivalent) vaccination may seem alarming, but context is critical.
The mortality rate of 4.35% warrants monitoring, though VAERS deaths represent temporal associations, not confirmed causal links.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.